Literature DB >> 12007592

Indicators of medication compliance in first-episode psychosis.

Olli Kampman1, Pekka Laippala, Juha Väänänen, Elina Koivisto, Päivi Kiviniemi, Nina Kilkku, Klaus Lehtinen.   

Abstract

Compliance behaviour is a multi-factorial phenomenon. In psychotic patients, it includes patient-related, medication-related, and environmental components. Compliance is a crucial factor in relation to outcome. The aim of this study was to explore indicators of compliance in a sample of 59 patients with a first-onset psychosis during their initial phase of treatment. Dependent variables in the logistic regression analysis included predictions made by the patients about their compliance in the initial phase and the observed compliance during the first 3 months according to patient record data. Explanatory variables comprised age, sex, living situation, education and social activities, Positive and Negative Syndrome Scale (PANSS) score, Hamilton Depression Scale score, Global Assessment of Functioning Scale score, Strauss-Carpenter Outcome Scale score, self-rated side effects, and insight and treatment-related variables. Predictions made by the patients about their compliance were determined by their self-rated attitude and insight measures. Determinants of observed non-compliance included experienced harmful side effects, male sex, lack of social activities, low score on PANSS positive symptoms, high PANSS total score and young age. The duration of untreated psychosis was not associated with compliance. Indicators of compliance in first-episode psychosis resemble those in the overall psychotic population. During the acute phase of psychosis, insight and attitudes toward treatment are the sole determinants of the patients' prediction of compliance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007592     DOI: 10.1016/s0165-1781(02)00030-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  23 in total

Review 1.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

2.  Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Authors:  Prakash S Masand; Miquel Roca; Martin S Turner; John M Kane
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

3.  Exploring variables associated with medication non-adherence in patients with COPD.

Authors:  Anan S Jarab; Tareq L Mukattash
Journal:  Int J Clin Pharm       Date:  2019-08-30

4.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

5.  Religious beliefs in schizophrenia: their relevance for adherence to treatment.

Authors:  L Borras; S Mohr; P-Y Brandt; C Gilliéron; A Eytan; P Huguelet
Journal:  Schizophr Bull       Date:  2007-01-09       Impact factor: 9.306

6.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

7.  A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.

Authors:  Seung Jae Lee; Jong Hun Lee; Sung Won Jung; Bon Hoon Koo; Tae Young Choi; Kwang Hun Lee
Journal:  Clin Drug Investig       Date:  2012-11       Impact factor: 2.859

8.  Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical Africa.

Authors:  Noémie Resseguier; Vanessa Machault; Lénaick Ollivier; Eve Orlandi-Pradines; Gaetan Texier; Bruno Pradines; Jean Gaudart; Alain Buguet; Catherine Tourette-Turgis; Christophe Rogier
Journal:  Malar J       Date:  2010-02-03       Impact factor: 2.979

9.  Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: immediate and long-term effects using a blind randomized controlled trial.

Authors:  Maite Ferrin; J M Moreno-Granados; M D Salcedo-Marin; M Ruiz-Veguilla; V Perez-Ayala; E Taylor
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-12-01       Impact factor: 4.785

10.  Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

Authors:  Kit Wa Sherry Chan; Men Heng Marian Wong; Christy Lai Ming Hui; Edwin Ho Ming Lee; Wing Chung Chang; Eric Yu Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.